Ruzurgi (2021-09-09)
· Published by Health Canada · Official notice
Alert type: Drug Recall
Category: Drugs
Issue: Product Safety
Audience: General Public, Healthcare Professionals, Hospitals
Department: Health Canada
Hazard classification: Type II
Ruzurgi
| Lot or serial number | Brand name | Companies | DIN, NPN, DIN-HIM | Dosage form | Strength |
|---|
| 18038 | Ruzurgi | - Recalling Firm
- Medunik Canada
- 950 Michèle-Bohec
- Blainville
- J7C 5E2
- Quebec
- CANADA
- Marketing Authorization Holder
- Medunik Canada
- 950 Michèle-Bohec
- Blainville
- J7C 5E2
- Quebec
- CANADA
| DIN 02503034 | Tablet | Amifampridine 10 mg |
Total combinated yeasts and molds count (TYMC) is out of specification in the affected lot.
Wholesalers, Retailers, End users.